These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 36212503)
1. Nomograms for prediction of breast cancer in breast imaging reporting and data system (BI-RADS) ultrasound category 4 or 5 lesions: A single-center retrospective study based on radiomics features. Hong ZL; Chen S; Peng XR; Li JW; Yang JC; Wu SS Front Oncol; 2022; 12():894476. PubMed ID: 36212503 [TBL] [Abstract][Full Text] [Related]
2. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS. Luo WQ; Huang QX; Huang XW; Hu HT; Zeng FQ; Wang W Sci Rep; 2019 Aug; 9(1):11921. PubMed ID: 31417138 [TBL] [Abstract][Full Text] [Related]
3. Photoacoustic Imaging Radiomics to Identify Breast Cancer in BI-RADS 4 or 5 Lesions. Li G; Huang Z; Luo H; Tian H; Ding Z; Deng Y; Xu J; Wu H; Dong F Clin Breast Cancer; 2024 Jul; 24(5):e379-e388.e1. PubMed ID: 38548517 [TBL] [Abstract][Full Text] [Related]
4. Nomogram based on radiomics analysis of primary breast cancer ultrasound images: prediction of axillary lymph node tumor burden in patients. Gao Y; Luo Y; Zhao C; Xiao M; Ma L; Li W; Qin J; Zhu Q; Jiang Y Eur Radiol; 2021 Feb; 31(2):928-937. PubMed ID: 32845388 [TBL] [Abstract][Full Text] [Related]
5. Combining Potential Strain Elastography and Radiomics for Diagnosing Breast Lesions in BI-RADS 4: Construction and Validation a Predictive Nomogram. Zha H; Wu T; Zhang M; Cai M; Diao X; Li F; Wu R; Du Y Acad Radiol; 2024 Aug; 31(8):3106-3116. PubMed ID: 38378324 [TBL] [Abstract][Full Text] [Related]
6. An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions. Zhang R; Wei W; Li R; Li J; Zhou Z; Ma M; Zhao R; Zhao X Front Oncol; 2021; 11():733260. PubMed ID: 35155178 [TBL] [Abstract][Full Text] [Related]
7. Automatic Breast Volume Scanner and B-Ultrasound-Based Radiomics Nomogram for Clinician Management of BI-RADS 4A Lesions. Ma Q; Wang J; Xu D; Zhu C; Qin J; Wu Y; Gao Y; Zhang C Acad Radiol; 2023 Aug; 30(8):1628-1637. PubMed ID: 36456445 [TBL] [Abstract][Full Text] [Related]
8. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm. Lin F; Wang Z; Zhang K; Yang P; Ma H; Shi Y; Liu M; Wang Q; Cui J; Mao N; Xie H Front Oncol; 2020; 10():573630. PubMed ID: 33194677 [TBL] [Abstract][Full Text] [Related]
9. An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography Category 4A Lesions. Hai L; Feng Y; Zhao J; Tang Q; Wang X; Cao X; Xiao C Cancer Control; 2022; 29():10732748221122703. PubMed ID: 37735939 [TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions. Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P Front Oncol; 2021; 11():825429. PubMed ID: 35155214 [TBL] [Abstract][Full Text] [Related]
11. Development of a nomogram-based model combining intra- and peritumoral ultrasound radiomics with clinical features for differentiating benign from malignant in Breast Imaging Reporting and Data System category 3-5 nodules. Zhong L; Shi L; Zhou L; Liu X; Gu L; Bai W Quant Imaging Med Surg; 2023 Oct; 13(10):6899-6910. PubMed ID: 37869276 [TBL] [Abstract][Full Text] [Related]
12. A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment. Xu Z; Lin Y; Huo J; Gao Y; Lu J; Liang Y; Li L; Jiang Z; Du L; Lang T; Wen G; Li Y Eur Radiol; 2024 Apr; 34(4):2608-2618. PubMed ID: 37840099 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Nomogram for Predicting Breast Malignancy in Male Patients Based on Clinical and Ultrasound Features. Dong WH; Wu G; Zhao N; Zhang J Curr Radiopharm; 2024; 17(3):266-275. PubMed ID: 38288830 [TBL] [Abstract][Full Text] [Related]
14. A new nomogram for predicting the malignant diagnosis of Breast Imaging Reporting and Data System (BI-RADS) ultrasonography category 4A lesions in women with dense breast tissue in the diagnostic setting. Yang Y; Hu Y; Shen S; Jiang X; Gu R; Wang H; Liu F; Mei J; Liang J; Jia H; Liu Q; Gong C Quant Imaging Med Surg; 2021 Jul; 11(7):3005-3017. PubMed ID: 34249630 [TBL] [Abstract][Full Text] [Related]
15. Prediction of the Malignancy of a Breast Lesion Detected on Breast Ultrasound: Radiomics Applied to Clinical Practice. Nicosia L; Pesapane F; Bozzini AC; Latronico A; Rotili A; Ferrari F; Signorelli G; Raimondi S; Vignati S; Gaeta A; Bellerba F; Origgi D; De Marco P; Castiglione Minischetti G; Sangalli C; Montesano M; Palma S; Cassano E Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765921 [TBL] [Abstract][Full Text] [Related]
16. A Machine Learning Ensemble Based on Radiomics to Predict BI-RADS Category and Reduce the Biopsy Rate of Ultrasound-Detected Suspicious Breast Masses. Interlenghi M; Salvatore C; Magni V; Caldara G; Schiavon E; Cozzi A; Schiaffino S; Carbonaro LA; Castiglioni I; Sardanelli F Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054354 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of diagnostic efficacy of multimode ultrasound in BI-RADS 4 breast neoplasms and establishment of a predictive model. Chen Y; Lu J; Li J; Liao J; Huang X; Zhang B Front Oncol; 2022; 12():1053280. PubMed ID: 36505867 [TBL] [Abstract][Full Text] [Related]
18. Radiomics Based on DCE-MRI Improved Diagnostic Performance Compared to BI-RADS Analysis in Identifying Sclerosing Adenosis of the Breast. Ruan M; Ding Z; Shan Y; Pan S; Shao C; Xu W; Zhen T; Pang P; Shen Q Front Oncol; 2022; 12():888141. PubMed ID: 35646630 [TBL] [Abstract][Full Text] [Related]
19. Radiomics Based on Digital Mammography Helps to Identify Mammographic Masses Suspicious for Cancer. Wang G; Shi D; Guo Q; Zhang H; Wang S; Ren K Front Oncol; 2022; 12():843436. PubMed ID: 35433437 [TBL] [Abstract][Full Text] [Related]
20. [Differential diagnosis model of benign and malignant breast BI-RADS category 4 nodules based on serum SP70 and conventional laboratory indicators]. Ding HM; Xu J; Wang F; Zhang Q; Pan H; Mu Y; Gu CR; Miao SX; Li XN; Ju HY; Wang L; Pan SY Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1774-1783. PubMed ID: 36536565 [No Abstract] [Full Text] [Related] [Next] [New Search]